Clinical trials
Phase 2 Amyloid Neuropathies, Familial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Seoul National University Hospital | 1 |
| University of Tennessee Graduate School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloid Neuropathies, Familial | 4 |
| Amyloidosis | 2 |
| Alzheimer Disease | 1 |
| Cardiomyopathies | 1 |
| Carpal Tunnel Syndrome | 1 |
| Spinal Stenosis | 1 |
Trials
Showing 76 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.